Incannex Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Incannex board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Incannex Board Today - Breaking & Trending Today

Incannex Announces Positive Topline Results from Phase 2

Highlights: PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of 12.8. ....

South Australia , United States , Joel Latham , Paul Liknaitzky , Laine Yonker , Edison Group , Clinical Psychedelic Lab At Monash University , Incannex Healthcare Inc , Drug Administration , Investigational New Drug , Clinical Psychedelic Lab , Monash University , About Generalised Anxiety , Anxiety Disorder , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Existing Registered Treatments ,

Incannex Announces Positive Topline Results from Phase 2 Psi-GAD1 Clinical Trial of Psilocybin in Generalised Anxiety Disorder

Highlights:PsiGAD1 trial achieves primary endpoint; PsiGAD psilocybin-assisted therapy demonstrated a statistically significant HAM-A reduction of. ....

South Australia , United States , Laine Yonker , Joel Latham , Paul Liknaitzky , Incannex Healthcare Inc , Edison Group , Drug Administration , Clinical Psychedelic Lab At Monash University , Investigational New Drug , Clinical Psychedelic Lab , Monash University , About Generalised Anxiety , Anxiety Disorder , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Existing Registered Treatments ,

Incannex Completes Successful Pre-IND Meeting with the FDA for CannQuit-N; a Novel Solution for Tobacco Smoking Cessation

MELBOURNE, Australia and NEW YORK, Feb. 16, 2024 (GLOBE NEWSWIRE) Incannex Healthcare Inc. (Nasdaq: IXHL), (Incannex or the Company), a leading cannabinoid and psychedelic medicine biotechnology company, is pleased to announce the successful completion of a pre-IND (Investigational New Drug) meeting with the U.S. Food and Drug Administration (FDA) regarding the development of CannQuit-N for tobacco smoking cessation and control of relapse. The pre-IND teleconference included representatives f ....

United States , Laine Yonker , Joel Latham , Drug Administration , Edison Group , Incannex Healthcare Inc , Investigational New Drug , Incannex Board , Securities Litigation Reform Act , Executive Officer , Relations Contact , Nicotine Replacement Therapy , Nicotine Addiction , Incannex Healthcare Inc , Food And Drug Administration , Investigational New Drug , Chewing Gum , Development Program , Continued Development , The Company , Cigarette Smoking , B1 Receptor , Smoking Cessation ,

Clarion Clinics Receives Ethics Board Endorsement For The First Dedicated Psychedelic-Assisted Therapy Clinic In Australia

Clarion Clinics Receives Ethics Board Endorsement For The First Dedicated Psychedelic-Assisted Therapy Clinic In Australia
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United States , Joel Latham , Peter Widdows , Incannex Healthcare Ltd Nasdaq , Edison Group , Incannex Healthcare Inc , Therapeutic Goods Administration , Human Research Ethics Committee , Clarion Clinics , Healthcare Ltd , Authorised Prescriber Scheme , Treatment Resistant Depression , Post Traumatic Stress Disorder , Authorised Prescriber , Melbourne Clarion Clinic , Yarra Riverfront , Incannex Board , Securities Litigation Reform Act , Relations Contact ,

Incannex Update on IHL-42X Drug Candidate in Phase 2/3 Clinical Trial in Obstructive Sleep Apnea

MELBOURNE, Australia and NEW YORK, Dec. 06, 2023 Incannex Healthcare Inc. , , a pharmaceutical company developing unique medicinal cannabinoid pharmacotherapies and psychedelic medicine. ....

United States , Joel Latham , National Health , Nutrition Examination , Health Foundation , Edison Group , Incannex Healthcare Inc , Globenewswire Inc , American Thoracic Society , Investigational New Drug , Incannex Board , Securities Litigation Reform Act , Chief Executive , Relations Contact , Med Rev , Disordered Breathing , Nutrition Examination Survey , Commercial Long Haul Truck Drivers , Sleep Disordered Breathing , Obstructive Sleep Apnea , Estimation Using Currently Available Data , Respir Med ,